Rush Medical Center Home Page Information for healthcare Professionals Rush University
FIND A DOCTOR
PATIENT & VISTOR SERVICES
HEALTH INFORMATION
CLINICAL SERVICES
EVENTS & CLASSES
RUSH NEWS ROOM
CLINICAL TRIALS
RESEARCH AT RUSH
NURSING AT RUSH
WORK AT RUSH
GIVING TO RUSH

Bookmark This Page
Clinical Trails at Rush Treatment of Mild Hepatic Encephalopathy Study
Clinical Trial Protocol ID
09033004

Clinical Trial Investigator Name
Shah Nikunj

Clinical Trial Title

Phase II randomized double blinded, placebo controlled trial to evaluate the safety and tolerability of an investigational drug in the treatment of mild hepatic encephalopathy.



Clinical Trial Protocol Description

The purpose of this study is to obtain information on the safety and the effectiveness of an experimental drug compared to placebo when it is used to treat mild encephalopathy.



Clinical Trial Eligibility Criteria

You may be eligible to participate in this study if you:

  • Are age 18-70
  • Have confirmed cirrhosis of any cause
  • Have companion willing to participate and attend two visits

You will be excluded from this study:

  • If you have history of TIPS
  • If you had treatment for an episode of overt hepatic encephalopathy within the past three months prior to screening
  • For active alcohol abuse

This is a partial list of eligibility requirements. To inquire about your eligibility, please call the contact number provided. If you wish to inquire via e-mail, please include the title of the study in your message.





Contact Name Doris Yadav
Contact Phone (312) 563-3919
Contact E-mail clinical_trials@rush.edu
Promotional Information

Clinical Trials Home
Hepatology Trials
Treatment of Mild Hepatic Encephalopathy Study

   
Find a Doctor | Patient & Visitor Services | Health Information
Clinical Services | Events & Classes | Rush News Room | Clinical Trials
Research At Rush
Disclaimer | Privacy Statement | Site Map

© Rush University Medical Center, Chicago, Illinois